Generic Name and Formulations:
Trivalent inactivated "split virus" influenza vaccine (Types A and B); formulation changes annually; susp for IM inj; contains thimerosal.
Novartis Pharmaceuticals Corp
Indications for FLUVIRIN:
Adults and Children:
<4yrs: not recommended. Each dose is 0.5mL IM. 4–8yrs: 2 doses at least 1 month apart for 1st immunization, otherwise 1 dose per season. >9yrs: 1 dose/season. Infants and young children: give in anterolateral thigh; older: give in deltoid muscle.
Allergy to egg proteins. Life-threatening reaction to any previous flu vaccine.
Use current formulation only. Guillain-Barre syndrome within 6 weeks of previous flu vaccine. Immunosuppressed. Have epinephrine inj (1:1000) available. Pregnancy (Cat.C). Nursing mothers.
Concomitant vaccines: insufficient data (see literature). Immunosuppressants (eg, radiation, chemotherapy, high-dose steroids) may result in suboptimal response.
Local reactions, headache, fever, malaise, fatigue, myalgia.
Multidose vial (5mL)—1
Single-dose prefilled syringes (0.5mL)—10
Neurology Advisor Articles
- FDA Approves Aimovig for Migraine Prevention
- Prediction Algorithm Stratifies ICH Patients at Risk for Hematoma Expansion
- Sports-Related Concussion Outcomes Predicted With Serum Neurofilament Light
- FDA Fast-Tracks Treatment for Autism Spectrum Disorder
- Psychological Therapies May Help Older Adults With Chronic Pain
- Amyloid Positivity Increases Risk for Cognitive Impairment in Dementia-Free Patients
- Valproic Acid-Related Adverse Fetal Outcomes May Be Linked to Placental Effects
- Risk of Dementia Up for Older Adults With Lowest Wealth
- Language Used in Medical Record Can Affect Patient Care
- Mortality in Alzheimer Disease Not Strongly Associated With Antipsychotics